. (2010). Sensitivity of the female rat to olanzapine-induced weight gain -far from the clinic?. Schizophrenia Research, 116 (2-3), 299-300.
its ability to mimic the human scenario. Indeed, reports indicate that male rats are less sensitive to olanzapine-induced weight gain than females. For example, contrary to female rats, male Sprague Dawley, Wistar and Mol:Wistar Hannover rats treated with olanzapine at a dosage range of 1 -20mg/kg/day failed to exhibit increased food intake or weight gain (Albaugh et al., 2006; Pouzet et al., 2003) . However, Minet-Ringuet et al. (2006) found that olanzapine (1mg/kg) treatment for 6-weeks increased adiposity and circulating leptin levels in male rats, indicating that olanzapine's enhancement of adiposity and leptin can be replicated in the rat model for both sexes.
Based on clinical data, we suggest that the rodent model of olanzapine-induced weight gain mimics aspects of the human situation as studies have revealed gender-related differences in the human response to olanzapine treatment. Evidence shows that females with psychotic disorder have a 3.6-fold increased risk of weight gain than males (Hakko et al., 2006) and previous studies have identified female gender as a risk factor and predictor for weight gain associated with olanzapine and other atypical antipsychotics (Gebhardt et al., 2009 ). In fact, Wu and colleagues (2007) reported that female first-episode schizophrenia patients had a higher hip to waist ratio, increased insulin-resistance and higher plasma triglycerides than males following treatment with olanzapine and clozapine. Kluge and others (2009) found that olanzapine significantly increased the BMI of female patients after 1-week treatment, however male patients took longer to reach significance, and females exhibited increased skin-fold thickness but not males. Females also showed a 2-4 times higher level of plasma leptin than males following olanzapine treatment, and this increase was observed earlier in females than in male patients (Kluge et al., 2009 ). Furthermore, female schizophrenia patients are more responsive to olanzapine treatment than male patients, regardless of illness chronicity (Usall et al., 2007) . Female patients also exhibit higher plasma concentrations of the drug than males (Kelly et al., 1999) , possibly due to their generally lower lean body mass and increased adipose tissue, allowing greater drug storage and leading to higher plasma levels over time (Yonkers et al., 1992) . Gonadal steroids such as oestrogen, progesterone and testosterone can influence food intake and metabolism. Fitzgerald and colleagues (2003) Taken together, the rodent model olanzapine-induced weight gain cannot completely replicate human weight gain side-effect, particularly in male rats. However, the sensitivity of female rodents to this side-effect over males appears to be a common observation in the clinic. Future studies on sex differences in the rodent model may improve our understanding of the mechanisms underlying gender response to antipsychotic effects.
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